SWOG clinical trial number
SWOG-8743

A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients with Metastatic Colorectal Adenocarcinoma

Closed
Phase
Accrual
71%
Published
Abbreviated Title
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients with Metastatic Colorectal Adenocarcinoma
Activated
06/15/1988
Closed
01/01/1990

Publication Information Expand/Collapse

1990

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma. A Southwest Oncology Group study.

RP Whitehead;T Fleming;JS Macdonald;PJ Goodman;J Neefe;TJ Braun;LJ Swinnen;EM Hersh JBRM 9:588-591

A phase II study of recombinant tumor necrosis factor (rINF) in patients with metastatic colorectal adenocarcinoma. A Southwest Oncology Group study.

RP Whitehead;T Fleming;P Goodman;J Neefe;TJ Braun;LJ Swinnen;EM Hersh ASCO 9:106(#411)